Macias William L.
SEC insider (Form 3/4/5 filer). CIK 0001864280. Chief Medical Officer at Immunovant, Inc. (IMVT). 8 reported Form 4/5 transactions since Sep 2024; latest on Feb 19, 2025. Located in NEW YORK, NY.
Companies Macias William L. has filed insider reports for
- Immunovant, Inc. (IMVT): Officer, Chief Medical Officer
Macias William L.
CIK: 0001864280
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)8 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMVT
Immunovant, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Feb 19, 2025IMVT
Immunovant, Inc.
SaleDirect2.1K shares at avg. $20.86$43K - Jan 15, 2025IMVT
Immunovant, Inc.
SaleDirect94 shares at avg. $24.19$2K - Jan 15, 2025IMVT
Immunovant, Inc.
SaleDirect1.9K shares at avg. $23.81$45K - Jan 15, 2025IMVT
Immunovant, Inc.
SaleDirect387 shares at avg. $23.81$9K - Jan 15, 2025IMVT
Immunovant, Inc.
SaleDirect19 shares at avg. $24.19$459.61 - Nov 20, 2024IMVT
Immunovant, Inc.
SaleDirect3.4K shares at avg. $25.45$85K - Oct 16, 2024IMVT
Immunovant, Inc.
SaleDirect561 shares at avg. $28.79$16K - Oct 16, 2024IMVT
Immunovant, Inc.
SaleDirect2.6K shares at avg. $28.79$76K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 19, 2025 | IMVT Immunovant, Inc. | Sale | 2,055 | $20.86 | $42,867 | Direct |
| Jan 15, 2025 | IMVT Immunovant, Inc. | Sale | 94 | $24.19 | $2,274 | Direct |
| Jan 15, 2025 | IMVT Immunovant, Inc. | Sale | 1,883 | $23.81 | $44,834 | Direct |
| Jan 15, 2025 | IMVT Immunovant, Inc. | Sale | 387 | $23.81 | $9,214 | Direct |
| Jan 15, 2025 | IMVT Immunovant, Inc. | Sale | 19 | $24.19 | $460 | Direct |
| Nov 20, 2024 | IMVT Immunovant, Inc. | Sale | 3,353 | $25.45 | $85,334 | Direct |
| Oct 16, 2024 | IMVT Immunovant, Inc. | Sale | 561 | $28.79 | $16,151 | Direct |
| Oct 16, 2024 | IMVT Immunovant, Inc. | Sale | 2,627 | $28.79 | $75,631 | Direct |
1-8 of 8 transactions